SG11201405447QA - Therapies, vaccines, and predictive methods for infectious salmon anemia virus - Google Patents

Therapies, vaccines, and predictive methods for infectious salmon anemia virus

Info

Publication number
SG11201405447QA
SG11201405447QA SG11201405447QA SG11201405447QA SG11201405447QA SG 11201405447Q A SG11201405447Q A SG 11201405447QA SG 11201405447Q A SG11201405447Q A SG 11201405447QA SG 11201405447Q A SG11201405447Q A SG 11201405447QA SG 11201405447Q A SG11201405447Q A SG 11201405447QA
Authority
SG
Singapore
Prior art keywords
vaccines
therapies
anemia virus
predictive methods
infectious salmon
Prior art date
Application number
SG11201405447QA
Inventor
Samuel Bogoch
Elenore S Bogoch
Samuel Winston Bogoch
Anne-Elenore Bogoch Borsanyi
Original Assignee
Samuel Bogoch
Elenore S Bogoch
Samuel Winston Bogoch
Anne-Elenore Bogoch Borsanyi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samuel Bogoch, Elenore S Bogoch, Samuel Winston Bogoch, Anne-Elenore Bogoch Borsanyi filed Critical Samuel Bogoch
Publication of SG11201405447QA publication Critical patent/SG11201405447QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16051—Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11201405447QA 2012-03-09 2013-03-08 Therapies, vaccines, and predictive methods for infectious salmon anemia virus SG11201405447QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261609074P 2012-03-09 2012-03-09
PCT/US2013/030013 WO2013151662A2 (en) 2012-03-09 2013-03-08 Therapies, vaccines, and predictive methods for infectious salmon anemia virus

Publications (1)

Publication Number Publication Date
SG11201405447QA true SG11201405447QA (en) 2014-10-30

Family

ID=49157854

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201405447QA SG11201405447QA (en) 2012-03-09 2013-03-08 Therapies, vaccines, and predictive methods for infectious salmon anemia virus

Country Status (3)

Country Link
US (2) US20130243803A1 (en)
SG (1) SG11201405447QA (en)
WO (1) WO2013151662A2 (en)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1002708A (en) 1911-03-13 1911-09-05 Louis J Kreutzberg Molding-flask.
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US7176275B2 (en) 1998-09-04 2007-02-13 Samuel Bogoch Anthrax and small pox replikins and methods of use
DE60029327T2 (en) * 1999-08-07 2007-07-05 Novartis Ag NUCLEIC ACID AND AMINO-ACID SEQUENCES OF INFECTIOUS SALMON ANAEMIA VIRUS, AND THEIR USE AS VACCINES
US7420028B2 (en) 2001-03-27 2008-09-02 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences
US7894999B2 (en) 2001-03-27 2011-02-22 Samuel Bogoch Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds
US7452963B2 (en) 2001-03-27 2008-11-18 Samuel Bogoch Replikin peptides and antibodies therefore
US7442761B2 (en) 2003-06-06 2008-10-28 Samuel Bogoch Replikin peptides and uses thereof
US7189800B2 (en) 2001-03-27 2007-03-13 Samuel Bogoch Replikin peptides in rapid replication of glioma cells and in influenza epidemics
CA2442346C (en) * 2001-03-30 2016-10-04 Microtek International (1998) Ltd. Nucleic acids encoding isav polypeptides
EP1414848B1 (en) 2001-07-09 2011-12-21 Samuel Dr. Bogoch Replikin peptides and uses thereof
WO2005104754A2 (en) 2004-04-28 2005-11-10 Samuel Bogoch System and method for identifying complex patterns of amino acids
AU2006214332B2 (en) 2005-02-16 2012-03-22 Elenore S. Bogoch Replikin peptides and uses thereof
EP2092059A4 (en) 2006-10-24 2012-03-28 Bogoch Samuel A method of predicting influenza outbreaks
WO2008143717A2 (en) 2007-01-18 2008-11-27 Samuel Bogoch Methods of determining lethality of pathogens and malignancies involving replikin peak genes
MX2009013091A (en) 2007-05-30 2010-07-30 Bogoch Samuel Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture.
CA2720465A1 (en) 2008-04-23 2009-10-29 Samuel Bogoch Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
WO2010017514A2 (en) 2008-08-08 2010-02-11 Samuel Bogoch Methods of predicting cancer lethality using replikin counts
NZ595812A (en) 2009-04-23 2013-09-27 Samuel Bogoch Replikin-sequences for preventing/treating influenza and determining infectivity/lethality

Also Published As

Publication number Publication date
US20160375125A1 (en) 2016-12-29
WO2013151662A9 (en) 2014-01-03
WO2013151662A3 (en) 2013-11-14
WO2013151662A2 (en) 2013-10-10
US20130243803A1 (en) 2013-09-19

Similar Documents

Publication Publication Date Title
HK1226440A1 (en) Cmv vaccines
HK1207967A1 (en) Vaccine
EP2900264A4 (en) Glycoprotein preparations
SG11201404014PA (en) Methods for increasing the infectivity of viruses
EP2807252A4 (en) Methods for increasing the infectivity of viruses
ZA201503467B (en) M. tuberculosis vaccines
PL2935313T3 (en) Vaccines against hepatitis b virus
SG11201404726TA (en) Enhanced re-hosting capability for legacy hardware and software
IL229307A0 (en) Inactivated dengue virus vaccine
EP2876161A4 (en) Vaccine
HK1212332A1 (en) Hepatitis c virus inhibitors
GB201321144D0 (en) Improved oncolytic viruses
SG11201505464QA (en) Chromatography media for purifying vaccines and viruses
EP2771453A4 (en) Diatom-based vaccines
ZA201503036B (en) Chimeric vaccine antigens against hepatitis c virus
GB201301119D0 (en) Viral vaccines
GB201215184D0 (en) Therapeutic virus
SG11201405447QA (en) Therapies, vaccines, and predictive methods for infectious salmon anemia virus
SG11201507455WA (en) Hepatitis b virus vaccines
EP2817720A4 (en) Enhanced re-hosting capability for legacy hardware and software
GB201202090D0 (en) Vaccine
HK1198941A1 (en) Improved hcv vaccines and methods for using the same hcv
GB201211930D0 (en) Concept for all killer viruses
TWI515128B (en) Multi-orientation operation system and operating method thereof
GB201314063D0 (en) Virus